A report published Friday in the Morbidity and Mortality Weekly Report characterized the 2013-2014 influenza season as the first season since 2009 that H1N1 generated fewer levels of outpatient illness and mortality as compared with seasons when influenza A (H3N2) is predominant.
As healthcare decision-makers grapple with how to ensure access to specialty medications, the University of Michigan Center for Value-Based Insurance Design and the National Pharmaceutical Council on Monday released a new report, "Supporting Consumer Access to Specialty Medications Through Value-Based Insurance Design," which explores how value-based insurance design could be utilized to address specialty medication access concerns.
Upsher-Smith Laboratories on Wednesday announced that it has received final approval from the Food and Drug Administration for its new drug application for Vogelxo (testosterone) gel for topical use CIII.
McKesson Pharmacy Systems and Automation has launched a pilot program to test its Adherence Performance reporting solution and provide pharmacies with an adherence rating similar to the CMS Star Ratings provided to health plans.
Low-risk patients were three times less likely to be admitted to a hospital when they received medication therapy management from a pharmacist, according to the findings of a recent study that was highlighted in Forbes magazine.
For seniors older than 65, taking a daily supplement of vitamin D with calcium — but not vitamin D alone — can offer some protection against the risk of common bone fractures, according to an updated review from the Cochrane Library, as released by the Health Behavior News Service Tuesday.
In an effort to spotlight the importance of early detection of memory problems, the Alzheimer's Foundation of America on Monday announced it is collaborating with Rite Aid to offer free, confidential memory screenings at all Rite Aid stores on June 4, from 10 a.m. to 2 p.m.
Mylan announced on Monday that it has entered into a settlement and license agreement with Pfizer relating to Mylan's abbreviated new drug application filed with the U.S. Food and Drug Administration for celecoxib capsules in 50-mg, 100-mg, 200-mg and 400-mg strengths.
In North Dakota, a proposed ballot measure is on the table that, if approved, would repeal a 50-year-old section of state law that requires pharmacies to be majority-owned by pharmacists who are licensed in North Dakota, according to a local news report.
After CVS Caremark was given the green light to open MinuteClinics in Rhode Island — with imposed conditions — the state’s Department of Health has now revised its ruling and dropped some key conditions.
Surrey, England-based Forme Laboratories, which specializes in menopause dermatology, has brought its Stratum C skin care line developed for peri-menopausal and menopausal skin to women in the United States.
Looking to change sunscreen habits for those with darker skin tones, La Roche-Posay and the Women's Dermatologic Society have teamed up to take a stand by not just raising awareness, but encouraging true behavioral change through educating on two key motivators.
Mission Pharmacal on Thursday announced that it has begun the promotion of Elestrin (estradiol gel) 0.06% in the United States through an agreement with Meda AB. The drug is a used as a topical hormone replacement gel to help treat hot flashes caused by menopause.
Teva Pharmaceutical Industries announced on Friday that the U.S. District Court for the Northern District of West Virginia has denied a motion filed by Mylan and issued an opinion and order affirming a decision by the FDA under which Teva should receive sole 180-day “first-to-file” exclusivity for generic Celebrex (celecoxib) 100-, 200- and 400-mg capsules.